Monday, 21 March 2016
Photo of the week - lights, camera, action!
Cancer patients to benefit from Victorian Cancer Agency funded research at MHTP
 |
| Associate Professor Jake Shortt |
Monash Health Translation Precinct (MHTP) researchers
received close to $4.5 million in grants in the latest Victorian Cancer Agency (VCA) funding round,
announced last Friday.
Of the eleven projects supported through the VCA, four
will be led by Monash University’s School of Clinical Science researchers.
MHTP Head of Haematology Research, Associate Professor Jake
Shortt received nearly $2 million to lead a clinical trial in collaboration with the Alfred's Myeloma Research Group investigating a new
cancer treatment for Victorian myeloma patients.
“Our patients will receive a unique therapeutic antibody
called MDX1097 that recognises a molecule only present on the surface of
myeloma cells, and not normal cells,” said Associate Professor Shortt.
“The most exciting recent advance in myeloma treatment is
the introduction of immune therapies targeting myeloma cells—and we’re hoping
our immune therapy MDX1097 will also make a significant impact.”
Monash University Senior Research Fellow Dr Arun Azad and
Hudson Institute’s Associate Professor Ron Firestein also received $2 million
to determine whether particular prostate and colorectal cancer patients will
respond to a new class of cancer drug known as BET inhibitors.
“Our clinical trial, to be undertaken at the newly opened
Clinical Trials Unit at MHTP, is the first in the world to look at the
association between patients with a particular biomarker known as long non-coding RNA and the
potential benefit of BET inhibitors,” said Dr Azad who is also a Consultant
Medical Oncologist at Monash Health.
Professor Terry Haines and Professor Helen Truby, Head of
Department of Nutrition and Dietetics were awarded $300,000 to examine
different approaches for delivering an accelerated nutrition support program
for patients with stomach or oesophageal cancer.
Director of Research at Southern Physiotherapy Clinical
School, Professor Haines said he hopes to deliver programs to improve body
weight and quality of life for those newly diagnosed with stomach or
oesophageal cancer.
Regional and rural Australian cancer patients will also
benefit from MHTP research aiming to improve palliative care expertise outside
metropolitan cities.
Director of Supportive and Palliative Care at Monash Health,
Associate Professor Peter Poon received $141,000 to lead a telehealth project
to deliver earlier specialist palliative care to rural cancer patients,
especially those with difficult-to-manage symptoms.
“Working together with rural medical practitioners, our
project will lead to improved care planning, carer support and
multidisciplinary management,” said Associate Professor Poon.
VCA grant brings personalised cancer therapy one step closer
 |
| Dr Arun Azad |
A world-first clinical trial at Monash Health Translation
Precinct, funded by a Victorian Cancer Agency (VCA) grant, will determine if a
new class of drug is effective in prostate and colorectal cancer patients.
Prostate and colorectal cancers are two of the most commonly
diagnosed cancers in Australia. More
than 3000 men die of prostate cancer and over 4100 lives are claimed by
colorectal cancer every year in Australia.
Researchers at Monash University and the Hudson Institute of
Medical Research have received a highly competitive VCA grant worth $2 million
to determine whether particular prostate and colorectal cancer patients will
respond to a new class of cancer drug known as BET inhibitors.
“BET inhibitors are a new type of therapy that can slow down
the growth of cancers by switching off cancer genes,” said lead researcher Dr
Arun Azad, Senior Research Fellow at Monash University and Consultant Medical
Oncologist at Monash Health.
Unlike chemotherapy which indiscriminately attacks ‘good’
and ‘bad’ cells, BET inhibitors—a type of epigenetic therapy—work on a genetic
level to turn off the growth of cancer cells.
“We believe that patients who have a particular biomarker
known as long non-coding RNAs may respond best to BET inhibitor therapy.”
“Importantly, we can easily identify which patients have
these long non-coding RNA biomarkers through examining their tissue sample,”
added Dr Azad.
Dr Azad believes around 50% of prostate and colorectal
cancer patients have the RNA biomarker and predicts these patients will respond
well to the new class of drug.
“While there are other trials investigating BET inhibitors,
our clinical trial is the first in the world to look at the association between
patients with RNA molecules and BET inhibitors.”
“We’re ultimately hoping to increase the range of
therapeutic options available to prostate and colorectal cancer patients,”
added Dr Azad. “This is all about
personalised medicine; we want to be able to use the right drug for the right
patient.”
The collaborative research project builds on the previous
work of Hudson Institute’s Associate Professor Ron Firestein, who identified
the RNA biomarker and potential benefit of BET inhibitors in pre-clinical models
in his previous laboratory at Genentech Inc.
“Ensuring the
effectiveness of targeted cancer therapies not only improves survival rates but
provides another option to patients who invariably develop resistance to
chemotherapy,” said Associate Professor Firestein who is also co-lead
investigator on the study.
Undertaken at Monash Health, the trial will recruit twenty
five patients with advanced prostate or colorectal cancer and for whom other
treatments options have failed.
Dr Azad said that while there is a range of drugs that work
well in prostate and colorectal cancer, patients eventually become resistant so
more options are needed.
“We need to use these treatment options the smartest way we
can and not use the scattergun chemotherapy approach where we give all patients
the same treatment, and if 20% respond, that’s great.”
“What about the other 80% of patients for whom chemo was
never going to work, who suffered unnecessary toxicity, and wasted time, effort
and a lot of money?”
Dr Azad and Associate Professor Firestein are very
optimistic about the potential for epigenetic therapies like BET inhibitors.
“If we can define which patients will respond best to
treatment, we’re genuinely personalising cancer care,” said Dr Azad.
“Personalised cancer care is the Holy Grail—everyone wins
but most importantly the patients.”
Co-collaborators on this study
include Monash University’s Professor Gail Risbridger, Associate Professor Helen
Abud, colorectal surgeon Associate Professor Paul McMurrick and Cabrini’s Dr
Simon Wilkins.
MHTP-Monash bioinformatics recognised internationally
 |
| Ms Roxane Legaie in Rio de Janeiro |
MHTP-Monash senior
bioinformatician Roxane Legaie was recognised for her ouststanding data modelling at a premier international bioinformatics
forum in Brazil recently.
Ms Legaie
received the Best Presentation Award at the International Conference on
Bioinformatics, Computational and Systems Biology (ICBCSB 2016) in Rio de
Janeiro in February where she presented her work, "The importance of
including all data in a linear model for the analysis of RNAseq data".
The ICBCSB
is the premier interdisciplinary forum for researchers, practitioners and
educators to present and discuss innovations, trends, challenges and solutions
in bioinformatics, computational and systems biology.
“Studies looking at the changes in gene expression from RNAseq data often make use of linear models, and it is also common practice to focus on a subset of data for a comparison of interest, leaving aside the samples not involved in a particular comparison. This work demonstrated that such an approach does not provide the best results.”
The data used for Ms Legaie’s study came from patients with endometriosis, a common medical condition affecting the lower abdomen in women in which the endometrial tissue grows outside the womb.
“The human endometrium is a dynamic tissue, which undergoes cycles of growth and regression with each menstrual cycle. The mesenchymal stem cells (MSCs) present in the endometrium are likely responsible for this remarkable regenerative capacity, however recent studies suggested that MSCs also plays a role in the pathogenesis of endometriosis” said Head, Endometrial Stem Cell Biology Lab Associate Professor Gargett.
RNA sequencing was used to compare gene expression profiles between MSCs and non-MSC counterparts obtained from women with or without endometriosis in the study.
“The results obtained when using only the subset of samples being tested were quite poor, with a limited number of significant differentially expressed (DE) genes identified. Performing the exact same statistical analysis but using all samples available in our dataset provided many more significant DE genes,” said Ms Legaie.
Those were key genes known to be involved in either endometriosis or stem cell differentiation (including the stem cell marker used in the experiment itself) and allowed for pathway analysis and further investigation in the lab.
The Monash Bioinformatics Platform provides expertise in biological research fields requiring cutting edge computational techniques such as genomics, proteomics and structural biology. Researchers are encouraged to meet with a bioinformatician before commencing a project to ensure the best experimental design is implemented.
Please contact Roxane Legaie for further information or read more here.
Monash represented at American College of Medical Toxicology Scientific Meeting
 |
| Prof Graudins and Dr Cooper |
Monash emergency and toxicology were represented at the American College of Medical Toxicology Scientific Meeting at Huntington
Beach, California last week.
Two recent Monash Emergency Medicine Trainees
participated at the meeting presenting their toxicology research projects
supervised by Professor Andis Graudins.
 |
| Dr Gone and Prof Graudins |
Dr Isabelle Cooper presented her pharmacokinetic study on
the bioavailability of intranasally administered droperidol. This research will
help guide clinical trials using this route of administration for conditions such as nausea, vomiting and migraine in the ED.
And Dr Santosh Gone presented a case of intentional severe
poisoning with pentobarbital with documented serum drug concentrations.
World Critical Care Congress 2019 to be hosted in Melbourne
 |
| Dr David Ku |
With high regard for Australian critical care globally, as
well as a strong bid by the Australia and New Zealand Intensive Care Society
(ANZICS) and the Australasian College of Critical Care Nurses (ACCCN),
Melbourne has won the bid to host the 2019 World Federation of Societies of
Intensive and Critical Care Medicine Congress (WFSICCM), the premier education
and research forum globally.
“Held every 2 years, this event allows critical care leaders
from its 80 critical care societies from around the world, both in developed
and developing countries, to collaborate on research, education and other meaningful
projects,” said WFSICCM Congress deputy convenor Dr David Ku, an Intensive Care
Consultant at Monash Health and Monash University Senior Lecturer.
“The 2019 Congress in Melbourne is unique as around a third
of the delegates and speakers will be from developing countries,” added Dr
Ku.
“And just like the World Congress of Nephrology (WCN), this
is the equivalent of the World Cup or Olympic Games of Critical Care.”
More than 4000 international delegates will participate in
the event over six days. Planning has
already started for the event, and Dr Ku hopes to showcase both the class of
Australian Intensive Care, as well as the hospitality and inclusiveness of our
city and people.
“This is likely to be the largest gathering of critical care
clinicians and researchers Australia has ever seen,” said Dr Ku.
MHTP Footy Tipping 2016
Well you work to earn a living, but on weekends comes the
time...
It's the start of the 2016 AFL season and the MHTP Footy Tipping Competition is back! $20 is all it takes to reserve your place in history.
It's the start of the 2016 AFL season and the MHTP Footy Tipping Competition is back! $20 is all it takes to reserve your place in history.
This year we have a base prize pool of $1500 graciously sponsored by the good people at Sarstedt and VWR. The top 3 tipsters will win 50% (1st), 30% (2nd) and 20% (3rd) of the remaining prize pool at the end of the season.
Last place tipster will get the Wooden Spoon (Refund of entry fee).
As before, there will be a weekly $5 jackpot to be shared by any members who tip a perfect round.
This year, after feedback, we will drop the joker rounds so everyone can bring their A Game.
Do you think you have what it takes to out-tip last years winner Rod Gillett?
Sign up and pay your entry fee in Stores before the siren!
http://www.footytips.com.au/comps/MHTP2016 Password: MHTP2016
Invitation - Smile for Mental Health Comedy Night TONIGHT
As part of the newly launched Mental Health Champions student leadership initiative, you are invited to the Smile for Mental Health comedy night.Taking place during Summerfest, on Tuesday 22nd of March from 7:30 to 9pm at the Central 1 Lecture Theatre, Clayton Campus, the event will provide a scorching selection of stand-up comedy with a unique twist from some of the Melbourne International Comedy Festival’s finest acts.
Our headline performers will be the much loved Sammy J (with his good friend Randy), and Damien Power as MC, with support from award winning comedians Laura Davis, David Rose, Jonathan Schuster and Naomi Higgins, this is an evening spectacle that is simply not to be missed. Curated by Monash University’s Mental Health Champions, the purpose of this event is to have a meaningful conversation about mental health, and have a smile doing so.
Tickets ($10 for students and $15 for adults) can be purchased here.
Monash Medical Orchestra performance Saturday 16 April
Saturday April 16th at 5pm
The Armadale Uniting Church, 86A Kooyong Road, Armadale
Tickets: $15 (purchase at the door or online at https://mumus.iwannaticket.com.au/event/mumus-presents-the-chamber-of-music-monash-medical-orchestras-charity-chamber-concert-MTA4MDc)
Friends and family are most welcome to attend!
They hope to see you there for an evening of merry music making!
SCS calendar - what's on
Did you know that SCS events, lectures, seminars and more are scheduled in the SCS calendar? You can subscribe to our calendar, ensuring you will receive invitations and never miss another event or meeting.
Just click on any of the scheduled events and you can easily add it to your own calendar.
The SCS calendar is on the front page of SCS eNews: (scsenews.blogspot.com.au). You can also add the SCS calendar to your list of calendars by clicking on the +Google calendar button.What's on for the week (22-28 Mar)
| Tue | 22/03/2016 | 12:00 PM | CID - Weekly Seminar Series |
| 12:00 PM | PhD Confirmation of Candidature - Sj Sijie Shen | ||
| 1:00 PM | CiiiD Seminar Series | ||
| 7:30 PM | Smile for Mental Health Comedy Night | ||
| Wed | 23/03/2016 | 9:30 AM | PhD Confirmation of Candidature - Charlotte Nejad |
| 12:00 PM | CiiiD Special Seminar: "Novel regulators of innate immune signalling" Dr Endre Kiss-toth | ||
| 12:30 PM | Grand Rounds “A Tricky Case of ITP” |
Forthcoming events (29 Mar-12Apr)
| Tue | 29/03/2016 | 1:00 PM | CiiiD Seminar Series |
| Wed | 30/03/2016 | 9:30 AM | PhD Confirmation of Candidature: Keren Grynberg |
| Tue | 05/04/2016 | 12:00 PM | CID - Weekly Seminar Series |
| 05/04/2016 | 1:00 PM | CiiiD Seminar Series | |
| 05/04/2016 | 3:00 PM | Monash BASE Facility Seminar Series: "Utilising the power of technology: Recruiting, retaining and engaging young adults in nutrition interventions" | |
| Tue | 12/04/2016 | 12:00 PM | CID - Weekly Seminar Series |
| 12/04/2016 | 1:00 PM | CiiiD Seminar Series |
CID Weekly Seminar: TODAY
 |
| Dr Keren Grynberg |
A light
lunch is served prior to the seminar at 11:45am in the seminar room foyer,
level 2, TRF Building.
Further information available from CID Weekly Seminar Series website [http://www.med.monash.edu.au/scs/medicine/cid/seminar-series.html
1. Dr
Keren Grynberg
Blockade
of JNK signalling in tubular epithelial cells prevents acute kidney injury
Dr Keren
Grynberg is a clinical nephrologist completing the first year of her Phd.
2. Mr Sj
Shen
Investigating
the role of dietary fibre in the modulation of immune function and leukocyte
recruitment during colitis
Sj Shen
is currently a PhD candidate at Monash Medical Centre (Clayton), supervised by
Dr. Connie Wong and Prof. Michael Hickey, with a research interest in the
effect of dietary fibre in a mouse model of Inflammatory Bowel Disease. He
completed Bachelor of Biomedical Sciences at Monash University (Clayton), which
included a unit of third year research examining the role of fibre in a mouse
model of asthma, taken under the supervision of Dr. Alison Thorburn. Sj then
undertook an Honours year with the Department of Immunology (Clayton) at Monash
University in the same lab, with research focus on the effect of diet in
experimental eosinophilic oesophagitis.
Grand Rounds 23 March “A Tricky Case of ITP”
Unit: Haematology
Presenter: Dr Sanjeev
Chunilal and Dr Allison Mo
Topic: “A Tricky Case of ITP”
Date:
Wednesday 23 March 2016
Time:
12.30pm to 1.30pm
Venue:
Main Lecture Theatre, Monash Medical Centre,
Clayton
CiiiD Special Seminar: "Novel regulators of innate immune signalling" Dr Endre Kiss-toth, 23 March
On Wednesday 23 March at 12pm, a special seminar will be
presented by Dr Endre Kiss-toth from the University of Sheffield.
The seminar will be held in the Level 2 seminar
rooms of the Hudson building. More information here.
Hudson Seminar: "Role and regulation of the epigenome during vertebrate development" 31 March
Next week's Hudson Seminar (Thurs 31st of March) will be held from 12-1 pm, Lecture Theatre 1, Monash Medical
Centre.
The speaker will be: Prof Ryan
Lister, Research Group Head, The Harry Perkins Institute of Medical Research
and The University of Western Australia.
Talk title: "Role and regulation of the epigenome during vertebrate development".
Flyer with details here.
Monash BASE Facility Seminar Series: "Utilising the power of technology: Recruiting, retaining and engaging young adults in nutrition interventions" 5 April
Visiting postdoctoral research fellow and dietitian Dr Melinda Hutchesson from the University of Newcastle, will present at the Monash BASE Faculty seminar series on Tuesday 5th
April at
3pm.
Dr Hutchesson's presentation is titled: Utilising the
power of technology: Recruiting, retaining and engaging young adults in
nutrition interventions
Dr Melinda Hutchesson is a dietitian and
Postdoctoral Research Fellow in the Priority Research Centre in Physical
Activity and Nutrition (PRC-PAN) at the University of Newcastle, Australia. Her
research focuses on the development, delivery and evaluation of lifestyle
interventions (nutrition and physical activity) to reduce the risk of chronic
disease risk factors (e.g. obesity). Her primary focus has been on the use of
eHealth technologies to deliver interventions, and the development of targeted
interventions for high-risk groups (e.g. young adults). Since PhD completion
(August 2011) she has held a variety of research positions, including 3
competitive postdoctoral fellowships (Penn Foundation Obesity Fellowship;
PRC-PAN Postdoctoral Fellowship; and National Heart Foundation Postdoctoral
Fellowship) and a senior research position to manage an ARC Linkage grant.
Melinda has published 46 peer reviewed manuscripts and been awarded over ½
million dollars in research funding. https://www.newcastle.edu.au/profile/melinda-hutchesson
Tuesday 5th of April at 3 PM
Meeting Room 4
Building 1, 270 Ferntree Gully Road, Notting Hill
World Health Summit 2016: Save the Date (9-11 October, Berlin)
3 Days – 40 Sessions – 250 Speakers (including Faculty of Medicine, Nursing and Health Sciences' Dean Professor Christina Mitchell)
From October 09-11, 2016, more than 1,500 experts from about 90 countries will be meeting up to develop novel solutions to the world’s most pressing health challenges.
This year’s central topics are:
• Migration and Refugee Health
• Technological Innovation for Health
• Women, Empowerment and Health
• Translational Research
• Infectious Diseases
• Sustainable Development Goals
Among the speakers (in alphabetical order):
• Hélène Boisjoly (Dean, Faculty of Medicine, Université de Montréal, Canada)
• Erwin Böttinger (CEO, Berlin Institute of Health, Germany)
• Christian Bréchot (President, Institut Pasteur, France)
• Emmanuelle Charpentier (Director, Max Planck Institute for Infection Biology, Germany)
• Philippe Douste-Blazy (Chairman of the Executive Board, UNITAID, France)
• Hermann Gröhe (Federal Minister of Health, Germany)
• Wolfgang Ischinger (Chairman, Munich Security Conference, Germany)
• Hon. Suresh Kumar (Executive Vice President External Affairs, Sanofi, France)
• Christina Mitchell (Dean, Monash University, Melbourne, Australia)
• Marisol Touraine (Minister of Social Affairs and Health, France)
Registration for the World Health Summit will open in early May 2016. A special Early Bird Ticket will be available until July 31.
The World Health Summit (WHS) brings together stakeholders and decision makers from every field in the healthcare spectrum, providing the perfect forum for exchange with experts from academia, politics, industry, and civil society. The world’s foremost strategic forum for global health is organized by the M8 Alliance of Academic Health Centers, Universities and National Academies.
Program overview and further information here.
VRCN 2016 Project Grants Funding Round - applications now OPEN
Applications are currently being sought for
project proposals from suitably qualified applicants to undertake research and
improvement projects that focus on the delivery of care for renal patients,
improving patient outcomes and the patient experience. We are specifically seeking to fund multidisciplinary, collaborative projects with a focus on quality improvement, implementation and which have the potential for state-wide applicability.
Unless otherwise state, applications must adhere to the VRCN 2016 Project Grants Application Guidelines (Attached here)
All applications must be submitted on the VRCN 2016 Project Grants Application Form (Attached here)
Applications or questions can be submitted via email on the application form to the following email address:
Renal.ClinicalNetwork@dhhs.vic.gov.au
Funding round timetable
Expressions
of interest open
|
Friday
18 March 2016
|
Closing
date for expression of interest
|
15
April 2016, 2:00pm
|
Endorsement
by VRCN Leadership Group
|
2
May 2016
|
Advice
to applicants
|
9
May 2016
|
Applications must be received by 2:00pm Friday 8 April 2016
Please note that incomplete or late applications will not be accepted
Flyer attached here.
Monash Warwick Alliance - 2016 Funding Schemes
The Monash Warwick Alliance Funding Schemes for 2016 have
been announced. The Funding Streams are:For Students:
Alliance Student-Led Activity Scheme round closing 11 April 2016.
The strategic alliance aims to enhance the experiences of students at both universities through the development of new models of education, research collaboration. The Student-led Activity Scheme provides a mechanism for students to get directly involved in activities that contribute to these aims. A maximum of AUD15,000 (for expenses incurred by Monash students) plus GBP10,000 (for expenses incurred by Warwick students). Projects which bring sponsorship or third-party funding or in-kind support are encouraged.
For Academic Staff:
Alliance Seed Fund round closing 11 April 2016.
The Alliance Seed Fund has been established with the specific intention to contribute to the support of new initiatives with high potential that combine complementary aspects of each institution towards novel research and educational outcomes. The Fund can contribute support of up to a maximum of AUD30,000 (for expenses incurred by Monash) plus GBP15,000 (for expenses incurred by Warwick) for new initiatives.These grants are awarded through a competitive selection process.
Alliance Visiting Scholars Program round closing 8 May 2016.
The purpose is to encourage exchange expertise in learning and teaching and to advance collaboration in areas of strategic priority. Selection Criteria will be based on technical and strategic merit & joint capacity. The duration is for 2-4 weeks and funds are up to $10,000.
Please refer to the web site for more information at: http://intranet.monash.edu.au/monash-warwick/funding-schemes/index.html
Queries should be directed to the Monash Warwick Alliance Project Coordinator, Mr Allan Mahler (allan.mahler@monash.edu).
ARC Future Fellowships 2016 (FT16) - APPLICATIONS NOW OPEN
Applications for ARC Future Fellowships
2016 are now open in RMS and
close 5pm on Tuesday 10 May 2016.
Please note that an earlier close date applies
for requests not to assess - see table below.
1. Please find links here to the Funding Rules summary, Funding rules for future fellowships, ARC Medical Policy, Instructions to Applicants and
Frequently Asked Questions.
2. Please start your
proposal in RMS as soon as possible so we know that you intend to
apply.
3. Please visit the
MRO intranet page for Future Fellowships (http://intranet.monash.edu.au/researchadmin/arc/arc-future-fellowships.html).
We will be posting any updates, certification and coversheet forms, as well as
templates to assist you with completing your application on this page.
4. Updates will also
be sent to the FT mailing list - sign-up here: http://intranet.monash.edu.au/researchadmin/arc/arc-updates.html or
posted via the MRO ARC Team App.
5. Due to the DECRA
round being open currently, please direct any questions that you have to the
ARC team email account where we will respond as quickly as we can: mro-arc@monash.edu
Key Dates:
FT1
6
|
MRO close date
|
ARC close date
|
Open in RMS 15 March 2016
|
||
Request Not to Assess
|
19 Apr 2016
|
5pm 26 Apr 2016
|
Proposal closing date
|
19 Apr 2016
|
5pm 10 May 2016
|
Strategic statement
|
19 Apr 2016
|
NA
|
Rejoinder Process
|
tba
|
July 2016
|
SCS Dragons Den 20 April
The School of Clinical
Sciences is hosting a Dragons’ Den style competition on Wednesday 20th
April, 5-7pm, in the new Translational Research Facility (TRF) at the Monash Health Translation Precinct.
The Dragons Den
competition was open to all current MBBS students at the School of Clinical
Sciences (SCS). Students were asked to submit viable project ideas they believed
would lead to innovations in curriculum delivery for the MBBS program at SCS.
Nine finalists were
chosen by a panel of SCS Academic and Professional staff and these finalists
will be pitching their ideas to a panel of ‘Dragons’ – Professor Eric Morand,
Professor Michelle Leech, Professor Julian Smith, Professor Erwin Loh and Dr Eugene Fredericks.
The Dragons will question the finalists on their ideas at
the conclusion of the pitch.
Register here to attend and support your
peers as they pitch their fantastic project ideas. Please note that space
is limited so register your attendance ASAP!!
Refreshments will be
served at the conclusion of the event.
PRIZES & AWARDS BULLETIN: A new Prime Minister’s Prize; Fresh Science and $50,000 stem cell prizes extended
|
|
|
|